Literature DB >> 29306996

YAP Promotes Migration and Invasion of Human Glioma Cells.

Yu Zhang1, Peng Xie1,2, Xu Wang3, Peng Pan1, Yan Wang3, Hao Zhang1, Yu Dong1, Yi Shi1, Yang Jiang1, Rutong Yu4,5, Xiuping Zhou6,7.   

Abstract

Previously, we have reported that Yes-associated protein (YAP) is upregulated in human glioma tissues and its level is positively correlated with patient prognosis. However, the role and mechanism of YAP in the highly invasive nature of human gliomas were largely unknown. In this study, examined by wound healing assay, transwell assay, or live-imaging, we found that YAP downregulation inhibited glioma cell migration and invasion, while YAP over-expression promoted them. Interestingly, the above effect of YAP on immortalized glioma cells was recapitulated in cultured primary glioma cells. In addition, the protein level of N-cadherin and Twist, two important proteins involved in tumor invasion, increased after YAP over-expression. Meanwhile, YAP over-expression significantly increased the F-actin level and changed the distribution of F-actin, leading to cytoskeletal reorganization, which plays an important role in cell motility. Furthermore, the promotion effect of YAP over-expression on glioma cell migration and invasion was partially abolished by Twist downregulation. Taken together, our findings show that YAP contributes to glioma cell migration and invasion by regulating N-cadherin and Twist, as well as cytoskeletal reorganization.

Entities:  

Keywords:  F-actin; Glioma; Migration; N-cadherin; Twist; YAP

Mesh:

Substances:

Year:  2018        PMID: 29306996     DOI: 10.1007/s12031-017-1018-6

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  14 in total

Review 1.  Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.

Authors:  Taohui Ouyang; Wei Meng; Meihua Li; Tao Hong; Na Zhang
Journal:  Cell Mol Neurobiol       Date:  2019-11-25       Impact factor: 5.046

2.  Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models.

Authors:  Anne Marie Barrette; Halle Ronk; Tanvi Joshi; Zarmeen Mussa; Meenakshi Mehrotra; Alexandros Bouras; German Nudelman; Joe Gerald Jesu Raj; Dominique Bozec; William Lam; Jane Houldsworth; Raymund Yong; Elena Zaslavsky; Constantinos G Hadjipanayis; Marc R Birtwistle; Nadejda M Tsankova
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

3.  Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.

Authors:  Xiujie Wu; Fan Feng; Chuanchao Yang; Moxuan Zhang; Yanhao Cheng; Yayun Zhao; Yayu Wang; Fengyuan Che; Jian Zhang; Xueyuan Heng
Journal:  J Mol Neurosci       Date:  2019-08-03       Impact factor: 3.444

4.  Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts.

Authors:  Do Kyeong Kim; Eun Kyoung Kim; Da-Woon Jung; Jin Kim
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

Review 5.  Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?

Authors:  Sarah Morice; Geoffroy Danieau; Françoise Rédini; Bénédicte Brounais-Le-Royer; Franck Verrecchia
Journal:  Cancers (Basel)       Date:  2020-03-10       Impact factor: 6.639

6.  BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas.

Authors:  Shangfeng Gao; Zhuang Sha; Junbo Zhou; Yihao Wu; Yunnong Song; Cheng Li; Xuejiao Liu; Tong Zhang; Rutong Yu
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

7.  YAP promotes autophagy and progression of gliomas via upregulating HMGB1.

Authors:  Min Zhao; Yu Zhang; Yang Jiang; Kai Wang; Xiang Wang; Ding Zhou; Yan Wang; Rutong Yu; Xiuping Zhou
Journal:  J Exp Clin Cancer Res       Date:  2021-03-16

8.  Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma.

Authors:  Jessica Tome-Garcia; Parsa Erfani; German Nudelman; Alexander M Tsankov; Igor Katsyv; Rut Tejero; Martin Walsh; Roland H Friedel; Elena Zaslavsky; Nadejda M Tsankova
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

9.  Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species.

Authors:  Katherine L Eales; Edward A Wilkinson; Garth Cruickshank; James H R Tucker; Daniel A Tennant
Journal:  Sci Rep       Date:  2018-09-25       Impact factor: 4.379

10.  YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27Kip1 mediated by Akt.

Authors:  Xiya Shen; Xingxing Xu; Changnan Xie; Huitao Liu; Danlu Yang; Jingjing Zhang; Qian Wu; Wenjin Feng; Ling Wang; Leilei Du; Lina Xuan; Chaobo Meng; Haitao Zhang; Wei Wang; Ying Wang; Tian Xie; Zhihui Huang
Journal:  Cell Prolif       Date:  2019-12-20       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.